Labcorp Holdings Analyst Price Targets

Wall Street analyst price targets and consensus rating for Labcorp Holdings (LH).

Price Target Range — 12 Quarters

Analyst Consensus — 16 Analysts

14Buy

2Hold

Consensus RatingBuy# Analysts16Avg. Consensus PT$302Upside to Avg. PT-17.4%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 21, 2026	Truist Securities	David Macdonald	PT Raise	Buy	$350→$365
Sep 11, 2026	UBS	Kevin Caliendo	PT Raise	Buy	$361→$380
Sep 11, 2026	Barclays	Luke Sergott	PT Raise	Equal-Weight	$320→$330
Aug 4, 2026	Piper Sandler	David Westenberg	PT Raise	Neutral	$300→$309
Aug 3, 2026	JP Morgan	Lisa Gill	PT Raise	Overweight	$330→$360
Jul 31, 2026	Morgan Stanley	Ricky Goldwasser	PT Raise	Overweight	$308→$338
Jul 31, 2026	Truist Securities	David Macdonald	PT Raise	Buy	$320→$350
Jul 31, 2026	Barclays	Jack Meehan	PT Raise	Equal-Weight	$290→$320
Jul 13, 2026	B of A Securities	Michael Ryskin	PT Raise	Buy	$300→$320
Jul 13, 2026	Baird	Eric Coldwell	PT Raise	Outperform	$335→$338
Apr 8, 2026	Evercore ISI Group	Elizabeth Anderson	PT Raise	Outperform	$280→$300
Feb 24, 2026	Piper Sandler	David Westenberg	PT Raise	Neutral	$270→$300
Feb 18, 2026	JP Morgan	Lisa Gill	PT Raise	Overweight	$319→$330
Feb 18, 2026	Baird	Eric Coldwell	PT Raise	Outperform	$313→$326
Feb 6, 2026	JP Morgan	Lisa Gill	PT Raise	Overweight	$317→$319
Nov 7, 2025	JP Morgan	Lisa Gill	PT Raise	Overweight	$291→$317
Oct 29, 2025	UBS	Kevin Caliendo	PT Cut	Buy	$325→$320
Oct 17, 2025	UBS	Kevin Caliendo	PT Raise	Buy	$305→$325
Oct 17, 2025	Mizuho	Ann Hynes	PT Raise	Outperform	$285→$320
Oct 3, 2025	Evercore ISI Group	Elizabeth Anderson	PT Raise	Outperform	$300→$305

Analyst Ratings News

PRO
Truist Securities Maintains Buy on Labcorp Holdings, Raises Price Target to $365

Truist Securities analyst David Macdonald maintains Labcorp Holdings (NYSE:LH) with a Buy and raises the price target from $350 to $365.

Benzinga Newsdesk

PRO
UBS Maintains Buy on Labcorp Holdings, Raises Price Target to $380

UBS analyst Kevin Caliendo maintains Labcorp Holdings (NYSE:LH) with a Buy and raises the price target from $361 to $380.

Benzinga Newsdesk

PRO
Barclays Maintains Equal-Weight on Labcorp Holdings, Raises Price Target to $330

Barclays analyst Luke Sergott maintains Labcorp Holdings (NYSE:LH) with a Equal-Weight and raises the price target from $320 to $330.

Benzinga Newsdesk

PRO
JP Morgan Maintains Overweight on Labcorp Holdings, Raises Price Target to $360

JP Morgan analyst Lisa Gill maintains Labcorp Holdings (NYSE:LH) with a Overweight and raises the price target from $330 to $360.

Benzinga Newsdesk

PRO
Morgan Stanley Maintains Overweight on Labcorp Holdings, Raises Price Target to $338

Morgan Stanley analyst Ricky Goldwasser maintains Labcorp Holdings (NYSE:LH) with a Overweight and raises the price target from $308 to $338.

Benzinga Newsdesk

PRO
Truist Securities Maintains Buy on Labcorp Holdings, Raises Price Target to $350

Truist Securities analyst David Macdonald maintains Labcorp Holdings (NYSE:LH) with a Buy and raises the price target from $320 to $350.

Benzinga Newsdesk

Labcorp Holdings Inc

뉴스

파트너 / 기고자

벤징가 글로벌

Labcorp Holdings Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Truist Securities Maintains Buy on Labcorp Holdings, Raises Price Target to $365

PRO
UBS Maintains Buy on Labcorp Holdings, Raises Price Target to $380

PRO
Barclays Maintains Equal-Weight on Labcorp Holdings, Raises Price Target to $330

PRO
JP Morgan Maintains Overweight on Labcorp Holdings, Raises Price Target to $360

PRO
Morgan Stanley Maintains Overweight on Labcorp Holdings, Raises Price Target to $338

PRO
Truist Securities Maintains Buy on Labcorp Holdings, Raises Price Target to $350

People Also Watch

People Also Watch

Labcorp Holdings Inc

뉴스

파트너 / 기고자

벤징가 글로벌

Labcorp Holdings Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROTruist Securities Maintains Buy on Labcorp Holdings, Raises Price Target to $365

PROUBS Maintains Buy on Labcorp Holdings, Raises Price Target to $380

PROBarclays Maintains Equal-Weight on Labcorp Holdings, Raises Price Target to $330

PROJP Morgan Maintains Overweight on Labcorp Holdings, Raises Price Target to $360

PROMorgan Stanley Maintains Overweight on Labcorp Holdings, Raises Price Target to $338

PROTruist Securities Maintains Buy on Labcorp Holdings, Raises Price Target to $350

People Also Watch

People Also Watch

PRO
Truist Securities Maintains Buy on Labcorp Holdings, Raises Price Target to $365

PRO
UBS Maintains Buy on Labcorp Holdings, Raises Price Target to $380

PRO
Barclays Maintains Equal-Weight on Labcorp Holdings, Raises Price Target to $330

PRO
JP Morgan Maintains Overweight on Labcorp Holdings, Raises Price Target to $360

PRO
Morgan Stanley Maintains Overweight on Labcorp Holdings, Raises Price Target to $338

PRO
Truist Securities Maintains Buy on Labcorp Holdings, Raises Price Target to $350